Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 39 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
WOLFS PHARMA from Liège, company number BE1017566820, closed financial year 2025 with a result of € 30,540 after tax. For that financial year WOLFS PHARMA recorded a gross margin of € 131,915 and equity of € 40,540. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.
€ 40,540
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 30,540
Profit after tax over the fiscal year.
€ 65,828
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 30,540.
People and assets in 2025
€ 55,142
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 6,150
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 227,792
€ 69,521 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 31,461
Supplier invoices still open on the last day of the fiscal year.
€ 21,314
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to WOLFS PHARMA?
What happened at WOLFS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 30,540. Source: NBB ↗
- New establishment in Liège. KBO
- Nathalie WOLFS became a director. NBB
- Start of the company according to the CBE. KBO
In short
Paid € 7,748 in corporate taxes since 2025.
A new publication or filing at WOLFS PHARMA? We notify you, reason included.
Follow WOLFS PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Nathalie WOLFS
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Rue Jean-Hermesse 45 box 1
4020 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1017.566.820
- VAT number
- BE 1017.566.820
- Registered office
- Rue Jean-Hermesse 45 bus 1, 4020 Liège
- Names & denominations
- WOLFS PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 2024
- Peppol
- Active · Active since 5 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten